Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial Pharmaceutical Investing
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference Pharmaceutical Investing
BioHarvest CEO Ilan Sobel: Disrupting Industries with Unique Products and Therapeutic Solutions Biotech Investing
AbbVie Provides Update Regarding SKYRIZI® for the Treatment of Moderate to Severe Crohn's Disease in the U.S. Pharmaceutical Investing
AbbVie Seeks New Indication for IMBRUVICA® in Pediatric Patients with Chronic Graft Versus Host Disease Pharmaceutical Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Opdivo Plus Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer Pharmaceutical Investing
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates Pharmaceutical Investing
NEW DATA FURTHER REINFORCE EFFICACY OF TEZSPIRE IN A BROAD POPULATION OF SEVERE ASTHMA PATIENTS Market News
